Navigation Links
HKTU Announces Development of a New Male Enhancement Supplement

CHICAGO, Feb. 14, 2013 /PRNewswire/ -- Hokutou Holdings International Inc. (OTCPINK: HKTU) has announced that it has developed a very potent male enhancement supplement that is all natural.

Eugene Collings , CEO of Hokutou, said that the Company began researching a way to develop a natural male enhancement supplement last year and has now developed what the Company believes to be a very potent supplement.  "When we think of health oriented supplements we don't typically think of male enhancement."  "However, we believe in the total health of all of our customers and male erectile dysfunction plagues a large percentage of men that make up our customer base so we definitely needed to enter the market with a potent supplement," said Collins.

The supplement helps to improve sexual stamina, endurance, strength, and energy with no side effects and lasts for up to 24 to 48 hours.  The supplement will be sold online first on the Company's online store and then later on Amazon. 

The Company's brand name is Live Young Naturals. The Company's mission is to provide effective healthy natural supplements to maintain and improve overall health and well-being. Additionally, the Company is passionate about pursuing cutting-edge innovations in the nutraceutical market that will assist those seeking greater wellness. The entire Live Young Naturals product line is manufactured in the U.S. at FDA-approved facilities.

For more information and a sneak peek at the Live Young Naturals products, visit

About Hokutou Holdings International Inc. 
Hokutou Holdings International Inc. was operated as a development stage company for the last three years. In July 2012, the majority interest of the Company was purchased by Chadwick & Collins. The Company is a nutraceutical company which distributes a product line of supplements under the moniker Live Young Naturals. The products are sold online and through the company's affiliate and distribution programs. The Company is dedicated to offering health conscious people safe and natural products at affordable prices. For additional information, please visit or call (815) 315-9738.

Forward-Looking Statements – Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby. The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties. 

SOURCE Hokutou Holdings International Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. STAAR Surgical Announces Fourth Quarter 2012 Results Release Date And Conference Call And Webcast
2. United Therapeutics Announces FDA Acceptance of Resubmission of Oral Treprostinil NDA
3. Breckenridge Announces Approval for Pioglitazone Hydrochloride tablets
4. Regulus Announces Timing for Fourth Quarter and Year-End 2012 Financial Results Webcast and Conference Call
5. CryoLife Announces Quarterly Cash Dividend for the First Quarter 2013
6. Xenon Announces Appointment of EVP, Research & Development
7. BiOptix announces expansion of Innovators Program at Molecular Med TRI-CON 2013
8. OncoGenex Announces Plans for the Initiation of the Borealis-2 Clinical Trial Evaluating OGX-427 in Combination with Second-Line Therapy for Bladder Cancer
9. OrbusNeich Announces Favorable Ruling From the European Patent Office
10. Trovagene Announces Commercial Launch Timelines for HPV Carrier and Oncogene Mutation Tests
11. Comprehensive Care Corporation Announces New Medicare Contract with Humana Health Plan of California, Inc.
Post Your Comments:
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a ... second affiliate in Latin America . ... ... ... ...
(Date:6/23/2016)... 23, 2016  Experian Health, the healthcare ... the patient payment and care experience, today ... products and services that will enhance the ... offerings. These award-winning solutions will enable healthcare ... compliant in an ever-changing environment and redefine ...
Breaking Medicine Technology:
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
Breaking Medicine News(10 mins):